1. % Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England

2. % Ratio of Spending on Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England

3. Trends in Prescribing of Hypnotics in General Practice in England

4. Trends in Spending on Hypnotics in General Practice in England

5. Quantities of "Z" drugs (Zaleplon, Zolpidem & Zopiclone) Prescribed in General Practice in England (Quarter to June 2008)

6. Quantities of Selected Hypnotics (Tabs/Caps) Prescribed in General Practice in England (Quarter to June 2008)

7. % of Prescriptions for Selected Hypnotics (Tabs/Caps) in General Practice in England for Defined Quantities (Quarter to June 2008)

8. Trends in Prescribing of Anxiolytics in General Practice in England

9. Trends in Spending on Anxiolytics in General Practice in England

10. Trends in Prescribing of Antipsychotic Drugs (BNF 4.2.1) in General Practice in England

11. Trends in Spending on Antipsychotic Drugs (BNF 4.2.1) in General Practice in England

12. Trends in Prescribing of "Typical" Antipsychotics in General Practice in England

13. Trends in Spending on "Typical" Antipsychotics in General Practice in England

14. Trends in Prescribing of "Atypical" Antipsychotics in General Practice in England

15. Trends in Spending on "Atypical" Antipsychotics in General Practice in England

16. Trends in Prescribing of Olanzapine Tablets by Strength in General Practice in England

17. Trends in Prescribing of Quetiapine by Strength in General Practice in England

18. Trends in Prescribing of Risperidone Tablets by Strength in General Practice in England

19. Trends in Prescribing of and Spending on Valproic Acid (Depakote®) in General Practice in England

20. Trends in Prescribing of and Spending on Lithium in General Practice in England

21. Trends in Prescribing of Antidepressants in General Practice in England

22. Trends in Spending on Antidepressants in General Practice in England

23. Trends in Prescribing of Tricyclic and related antidepressants in General Practice in England

24. Trends in Spending on Tricyclic and related antidepressants in General Practice in England

25. Trends in Prescribing of SSRIs in General Practice in England

26. Trends in Spending on SSRIs in General Practice in England

27. Trends in Prescribing of Other Antidepressant drugs (BNF 4.3.4) in General Practice in England

28. Trends in Spending on Other Antidepressant drugs (BNF 4.3.4) in General Practice in England

29. Trends in Prescribing of and Spending on Atomoxetine in General Practice in England

30. Trends in Prescribing of and Spending on Methylphenidate in General Practice in England

31. Trends in Prescribing of Methylphenidate Preparations in General Practice in England

32. Trends in Spending on Methylphenidate Preparations in General Practice in England

33. Trends in Prescribing of Methadone in General Practice in England

34. Trends in Spending on Methadone in General Practice in England

35. Trends in Prescribing of Methadone (Excluding Liquid Formulations) in General Practice in England

36. Trends in Prescribing of Older Antiepileptic Drugs in General Practice in England

37. Trends in Spending on Older Antiepileptic Drugs in General Practice in England

38. Trends in Prescribing of Newer Antiepileptic Drugs in General Practice in England

39. Trends in Spending on Newer Antiepileptic Drugs in General Practice in England

40. Trends in Prescribing of Co-beneldopa and Co-careldopa in General Practice in England

41. Trends in Spending on Co-beneldopa and Co-careldopa in General Practice in England

42. Trends in Prescribing of Other Dopaminergic Drugs used in Parkinsonism in General Practice in England

43. Trends in Spending on Other Dopaminergic Drugs used in Parkinsonism in General Practice in England

44. Trends in Prescribing of Antimuscarinic Drugs in General Practice in England

45. Trends in Spending on Antimuscarinic Drugs in General Practice in England

46. Trends in Prescribing of and Spending on Buprenorphine and Buprenorphine / Naloxone (BNF 4.10 Opioid Dependence) in General Practice in England

47. Trends in Prescribing of and Spending on Lofexidine in General Practice in England

48. Trends in Prescribing of and Spending on Naltrexone in General Practice in England

49. Trends in Prescribing of Drugs for Dementia in General Practice in England

50. Trends in Spending on Drugs for Dementia in General Practice in England

51. Trends in Prescribing of Melatonin in General Practice in England

52. Trends in Spending on Melatonin in General Practice in England

53. Trends in Instalment Dispensing Forms in General Practice in England